These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 3387441

  • 1. Biological activity of human-mouse IgG1, IgG2, IgG3, and IgG4 chimeric monoclonal antibodies with antitumor specificity.
    Steplewski Z, Sun LK, Shearman CW, Ghrayeb J, Daddona P, Koprowski H.
    Proc Natl Acad Sci U S A; 1988 Jul; 85(13):4852-6. PubMed ID: 3387441
    [Abstract] [Full Text] [Related]

  • 2. Comparative binding and preclinical localization and therapy studies with radiolabeled human chimeric and murine 17-1A monoclonal antibodies.
    Buchsbaum DJ, Brubaker PG, Hanna DE, Glatfelter AA, Terry VH, Guilbault DM, Steplewski Z.
    Cancer Res; 1990 Feb 01; 50(3 Suppl):993s-999s. PubMed ID: 2297753
    [Abstract] [Full Text] [Related]

  • 3. Binding and functional properties of a mouse-human chimeric monoclonal antibody of the human IgG1 subclass with specificity for human carcinomas.
    Liao SK, Horton L, Flahart RE, O'Rear L, Crumpacker D, Imbaratto JW, Yannelli JR, Robinson RR, Oldham RK.
    Hum Antibodies Hybridomas; 1990 Feb 01; 1(2):66-76. PubMed ID: 2103354
    [Abstract] [Full Text] [Related]

  • 4. Characterization of a mouse/human chimeric monoclonal antibody (17-1A) to a colon cancer tumor-associated antigen.
    Shaw DR, Khazaeli MB, Sun LK, Ghrayeb J, Daddona PE, McKinney S, LoBuglio AF.
    J Immunol; 1987 Jun 15; 138(12):4534-8. PubMed ID: 3584980
    [Abstract] [Full Text] [Related]

  • 5. Chimeric B72.3 mouse/human (IgG1) antibody directs the lysis of tumor cells by lymphokine-activated killer cells.
    Primus FJ, Pendurthi TK, Hutzell P, Kashmiri S, Slavin DC, Callahan R, Schlom J.
    Cancer Immunol Immunother; 1990 Jun 15; 31(6):349-57. PubMed ID: 2386980
    [Abstract] [Full Text] [Related]

  • 6. Section 1C: Assessment of the functional activity and IgG Fc receptor utilisation of 64 IgG Rh monoclonal antibodies. Coordinator's report.
    Kumpel BM, Beliard R, Brossard Y, Edelman L, de Haas M, Jackson DJ, Kooyman P, Ligthart PC, Monchâtre E, Overbeeke MA, Puillandre P, de Romeuf C, Wilkes AM.
    Transfus Clin Biol; 2002 Jan 15; 9(1):45-53. PubMed ID: 11889899
    [Abstract] [Full Text] [Related]

  • 7. Production and characterization of a set of mouse-human chimeric immunoglobulin G (IgG) subclass and IgA monoclonal antibodies with identical variable regions specific for Pseudomonas aeruginosa serogroup O6 lipopolysaccharide.
    Preston MJ, Gerçeker AA, Reff ME, Pier GB.
    Infect Immun; 1998 Sep 15; 66(9):4137-42. PubMed ID: 9712759
    [Abstract] [Full Text] [Related]

  • 8. Mechanism of antitumor activity in mice for anti-epidermal growth factor receptor monoclonal antibodies with different isotypes.
    Masui H, Moroyama T, Mendelsohn J.
    Cancer Res; 1986 Nov 15; 46(11):5592-8. PubMed ID: 3756906
    [Abstract] [Full Text] [Related]

  • 9. Antibody delivery and effector cell activation in a phase II trial of recombinant gamma-interferon and the murine monoclonal antibody CO17-1A in advanced colorectal carcinoma.
    Weiner LM, Moldofsky PJ, Gatenby RA, O'Dwyer J, O'Brien J, Litwin S, Comis RL.
    Cancer Res; 1988 May 01; 48(9):2568-73. PubMed ID: 3128400
    [Abstract] [Full Text] [Related]

  • 10. Analysis of effector cells in human antibody-dependent cellular cytotoxicity with murine monoclonal antibodies.
    Ortaldo JR, Woodhouse C, Morgan AC, Herberman RB, Cheresh DA, Reisfeld R.
    J Immunol; 1987 May 15; 138(10):3566-72. PubMed ID: 2437198
    [Abstract] [Full Text] [Related]

  • 11. A human-mouse chimeric Lym-1 monoclonal antibody with specificity for human lymphomas expressed in a baculovirus system.
    Hu P, Glasky MS, Yun A, Alauddin MM, Hornick JL, Khawli LA, Epstein AL.
    Hum Antibodies Hybridomas; 1995 May 15; 6(2):57-67. PubMed ID: 7492752
    [Abstract] [Full Text] [Related]

  • 12. Antitumor immune effector mechanisms recruited by phage display-derived fully human IgG1 and IgA1 monoclonal antibodies.
    Huls G, Heijnen IA, Cuomo E, van der Linden J, Boel E, van de Winkel JG, Logtenberg T.
    Cancer Res; 1999 Nov 15; 59(22):5778-84. PubMed ID: 10582699
    [Abstract] [Full Text] [Related]

  • 13. Induction of mouse IgG2a- and IgG3-dependent cellular cytotoxicity in human monocytic cells (U937) by immune interferon.
    Akiyama Y, Lubeck MD, Steplewski Z, Koprowski H.
    Cancer Res; 1984 Nov 15; 44(11):5127-31. PubMed ID: 6435864
    [Abstract] [Full Text] [Related]

  • 14. Human lymphocyte and monocyte lysis of tumor cells mediated by a mouse/human IgG1 chimeric monoclonal antibody.
    Shaw DR, Harrison G, Sun LK, Shearman C, Ghrayeb J, McKinney S, Daddona PE, LoBuglio AF.
    J Biol Response Mod; 1988 Apr 15; 7(2):204-11. PubMed ID: 3361351
    [Abstract] [Full Text] [Related]

  • 15. Hypothesis: macrophages as effector cells for human tumor destruction mediated by monoclonal antibody.
    Steplewski Z, Herlyn D, Maul G, Koprowski H.
    Hybridoma; 1983 Apr 15; 2(1):1-5. PubMed ID: 6678794
    [No Abstract] [Full Text] [Related]

  • 16. Effect of human blood mononuclear cell populations in antibody dependent cellular cytotoxicity (ADCC) using two murine (CO17-1A and Br55-2) and one chimeric (17-1A) monoclonal antibodies against a human colorectal carcinoma cell line (SW948).
    Masucci G, Lindemalm C, Frödin JE, Hagström B, Mellstedt H.
    Hybridoma; 1988 Oct 15; 7(5):429-40. PubMed ID: 3198133
    [Abstract] [Full Text] [Related]

  • 17. Mouse/human chimeric antibodies to a tumor-associated antigen: biologic activity of the four human IgG subclasses.
    Shaw DR, Khazaeli MB, LoBuglio AF.
    J Natl Cancer Inst; 1988 Dec 07; 80(19):1553-9. PubMed ID: 3143014
    [Abstract] [Full Text] [Related]

  • 18. Cytolytic activity of murine anti-dog lymphoma monoclonal antibodies with canine effector cells and complement.
    Rosales C, Jeglum KA, Obrocka M, Steplewski Z.
    Cell Immunol; 1988 Sep 07; 115(2):420-8. PubMed ID: 3409330
    [Abstract] [Full Text] [Related]

  • 19. Defucosylated chimeric anti-CC chemokine receptor 4 IgG1 with enhanced antibody-dependent cellular cytotoxicity shows potent therapeutic activity to T-cell leukemia and lymphoma.
    Niwa R, Shoji-Hosaka E, Sakurada M, Shinkawa T, Uchida K, Nakamura K, Matsushima K, Ueda R, Hanai N, Shitara K.
    Cancer Res; 2004 Mar 15; 64(6):2127-33. PubMed ID: 15026353
    [Abstract] [Full Text] [Related]

  • 20. Dose-related comparison of antibody-dependent cellular cytotoxicity with chimeric and native murine monoclonal antibody 17-1A. Improved cytolysis of pancreatic cancer cells with chimeric 17-1A.
    Haga Y, Sivinski CL, Woo D, Tempero MA.
    Int J Pancreatol; 1994 Feb 15; 15(1):43-50. PubMed ID: 8195641
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.